Contact HCVHome

For Researchers and
Technology Transfer Officers

Healthcare Ventures is seeking translational stage therapeutics (late preclinical to early clinical) from academic labs to advance through clinical proof-of-concept in project-focused companies. Through project-focused companies, we provide funding, access to a leading global development network, hands- on management by senior partners, and the opportunity for researchers to remain actively engaged with the project. Our aim is to deliver pipeline compounds with a high probability of success to pharmaceutical companies, and we seek early input from potential acquirers into our development programs.

Criteria for consideration include novel mechanisms of action; potential to transform the standard of care; target diseases where there are few therapeutic options; and potential for a strong intellectual property position. Therapeutic candidates may be either biologics or small molecules.

If you are interested in discussing a therapeutic candidate, please send a brief, non-confidential project summary along with relevant literature references to researchpro@hcven.com